Pharmaceutical Glass Packaging Market Analysis

Global Pharmaceutical Glass Packaging Market Overview

Pharmaceutical Glass Packaging Market Size was valued at USD 21,354.2 Million in 2023. The Global Pharmaceutical Glass Packaging industry is projected to grow from USD 22,913.06 Million in 2024 to USD 40,409.6 Million by 2032, exhibiting a compound annual growth rate (CAGR) of 7.3% during the forecast period (2024 - 2032).

Growth of the pharmaceutical industry in emerging economies, increasing demand for extending the shelf life of pharmaceutical items and increasing focus on anti-counterfeiting measures is driving the Pharmaceutical Glass Packaging Market.

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

• 
  

  Pharmaceutical Glass Packaging Market Trends

  
  

Growth of the pharmaceutical industry in emerging economies and increasing focus on anti-counterfeiting measures augmenting Pharmaceutical Glass Packaging Market.

Emerging markets are defined as expanding, rich nations where investment is expected to boost profits despite major risks. The BRICS countries (Brazil, Russia, India, China, and South Africa) are the leading developing economies. There are several techniques to categorizing lower-tier economies. Mexico, Indonesia, South Korea, and Turkey are among the few countries that are used as the MIST. Another interpretation distinguishes the two groupings as CIVETS (Colombia, Indonesia, Vietnam, Egypt, Turkey, and South Africa) and Bangladesh, Egypt, Indonesia, Iran, Korea, Mexico, Nigeria, Pakistan, the Philippines, Turkey, and Vietnam. While pharmaceutical sales are slowing in many developed countries, developing market sales patterns imply continued growth. Several economic and demographic factors influence the trend in these markets, including difficult conditions in existing markets where development has stalled due to patent expiration, cost-cutting initiatives that encourage generic replacement, and stringent enforcement of limitations.

The growing focus on anti-counterfeiting measures is extensively contributing to the marketplace growth. Counterfeit capsules pose big dangers to patient protection and public fitness, prompting regulatory authorities and pharmaceutical companies to take sturdy measures to fight this issue. Glass packaging offers inherent anti-counterfeiting capabilities that are difficult to copy or tamper with, making it a perfect choice for pharmaceutical merchandise. Furthermore, the glass bins can include unique embossing, holographic labels, and covert markings as authentication and identification measures. These capabilities ensure the authenticity of medicinal items and prevent counterfeiting. By the use of glass packaging, pharmaceutical agencies can guarantee patients and healthcare companies that the medicinal drugs they acquire are genuine and safe. Moreover, the rapid adoption of glass packaging as an anti-counterfeiting degree is driven by means of the need to shield patient health, hold logo reputation, and observe regulatory necessities.

Pharmaceutical Glass Packaging Market Segment Insights

Global Pharmaceutical Glass Packaging Product Type Insights

Based on product type, the market is segmented into vials, bottles & jars, cartridges & syringes, ampoules. The vials segment dominated the global market in 2023, while the bottles & jars is projected to be the fastest–growing segment during the forecast period. Vials refer to a small cylindrically shaped glass bottle used to store medication items, including liquids, capsules, and powders. Vials are also known as phial or flacon and used for storing specimen collections. The rising need for preserving the integrity of crime scenes by criminal investigators and the application of vials in forensic labs is driving the demand for vials in the global market. Furthermore, vials are used to carry multiple doses of drugs and can be sterilized and reused multiple times. Such factors are expected to drive the growth of this segment in the global market during the forecast period.

Global Pharmaceutical Glass Packaging Material Type Insights

Based on material type, the market is segmented into type I, type II, type III. The type I segment dominated the global market in 2023. Type I glass, often referred to as borosilicate glass, is characterized by its special composition containing boron molecules instead of alkaline oxides. This glass variant is chemically inert and highly resistant to various substances. It is widely regarded as the preferred choice for injectable medications and delicate treatments due to its exceptional stability.

Figure 1: Pharmaceutical Glass Packaging Market, by material type, 2023 & 2032 (USD Million)

Global Pharmaceutical Glass Packaging Application Insights

The application segment of the Pharmaceutical Glass Packaging Market size includes generic drugs, branded drugs, biological drugs. The generic drugs segment dominated the market in 2023, while the branded drugs segment is projected to be the fastest–growing segment during the forecast period. Generic drugs refer to those that are less expensive than brand-name drugs and are marketed without brand names. As per the United States Food and Drug Administration (FDA), these drugs have the same chemical composition as brand-name drugs and met the standard and regulations criteria in terms of dosage form, safety, strength, purity, quality, and characteristics. The consumption of generic drugs as a substitute to brand-name counterparts is increasing across the globe, creating a lucrative demand for the generic drugs market segment.

Global Pharmaceutical Glass Packaging Regional Insights

By Region, the study provides market insights into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The North America pharmaceutical glass packaging market accounted for largest market share in 2023 and is expected to exhibit a significant CAGR growth during the study period. The growth in funds for manufacturing regular medicines will be accountable for the expansion of the pharmaceutical glass packing sector in North America in the future years. The pharmaceutical glass packing market in the sub-continent is projected to evolve in the future due to the government's emphasis on creating long-term drugs for chronic diseases. It's estimated that the presence of major players in the region will greatly enhance regional market revenue over the next ten years. The increasing need for prescribed drugs and below-the-board medications is driving the pharmaceutical glass packing market in the United States. The increasing number of elderly individuals in the nation is also a significant contributor to the market's growth, as seniors typically require more medicines for long-term health problems. Additionally, advancements in pharmaceutical packing technology, including the enforcement of child-restrictive and tamper-evident packing, are supporting the growth of the market. A rise in health expenses led to an elevation in the production of regular drugs because of their more economical price. As health continues to lavish, there is an increasing demand for these medicines among the population. According to the Association for Reachable Medications, regular and biosimilar medicines saved America's patients and healthcare system, as well as employers and taxpayers, an aggregate of $408 billion in 2022. Over 90% of prescriptions were filled with these drugs, which comprised less than 18% of all prescription drug spending and less than 2% of total healthcare spending in the U.S. in 2022. Many times, these biosimilars are enclosed in glass bottles to avoid unexpected drug responses.

Figure 2: Pharmaceutical Glass Packaging Market, by region, 2023 & 2032 (USD Million)

Moreover, Asia Pacific is the second-largest region in the Pharmaceutical Glass Packaging Market. The Rising advancement of technology in the glass packaging of medications to yield advanced uses to the glass packaging of medicines are further increasing the markets. As India is a prominent and growing market in the world of medications, glass packaging demands are estimated to increase rapidly. India is the largest supplier of genetic medications in the world, accounting for 20% of all production and meeting over 62% of overall vaccine supply, as indicated by data provided on the Indian Brand Equity Foundation's website. India is the globe's largest medicine market with a value of 42.6 billion USD.

Additionally, the Europe pharmaceutical glass packaging market has grown significantly in recent years. Pharmaceutical manufacturing based on research is the most important positive feature of the financial system of Europe. The manufacturing of pharmaceutical glass packaging is increasing due to the escalation in medicinal development by way of exploration, expansion, and presentation of innovative medications intended for making better the patient’s physical condition as well as the class of life, within the region. High demand from pharmaceutical industry coupled with extensive utilization in generic injectable drugs is anticipated to drive the growth. Further, glass prevents atmospheric gases such as oxygen and carbon dioxide from entering the primary container, thereby preventing the contamination of the drugs. It also prevents the drug from potential degradation, such as oxidation and hydrolysis. In addition, glass packaging increases drug stability by resisting the escape of volatile ingredients.

Further, the major countries studied in the market report are the U.S., Canada, Mexico, Germany, France, Italy, UK, Spain, Japan, UAE, South Africa, Saudi Arabia, Argentina, and Brazil.

Global Pharmaceutical Glass Packaging Key Market Players & Competitive Insight

Many global, regional, and local vendors characterize the pharmaceutical glass packaging market. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, product quality, reliability, and government regulations. Vendors must provide cost-efficient, high-quality products to survive and succeed in an intensely competitive market.

The major players in the market include Gerresheimer AG, Nipro Corporation, Schott Pharmaceutical Packaging, Stevanato Group, Bormioli Pharma S.P.A, West Pharmaceutical Services, Inc, PGP Glass, Stölzle-Oberglas Gmbh, Arab Pharmaceutical Glass Co, And Ajanta Bottle, among others. The Pharmaceutical Glass Packaging Market is a consolidated market due to increasing competition, acquisitions, mergers and other strategic market developments and decisions to improve operational effectiveness.

Key Companies in the Pharmaceutical Glass Packaging Market include

• GERRESHEIMER AG


• STEVANATO GROUP


• NIPRO CORPORATION


• SCHOTT PHARMACEUTICAL PACKAGING


• BORMIOLI PHARMA S.P.A


• WEST PHARMACEUTICAL SERVICES, INC


• PGP GLASS


• STÖLZLE-OBERGLAS GMBH


• ARAB PHARMACEUTICAL GLASS CO


• AJANTA BOTTLE

Global Pharmaceutical Glass Packaging Industry Developments

• In March 2023, Bormioli Pharma announced a significant increase of 47% in its North American sales for 2023. This notable growth is a direct result of the company's rapidly evolving infrastructure and expanded capacity, tailored to meet the unique demands of the North American pharmaceutical market, including an increased need for pharmaceutical glass vials.


• In February 2023, SCHOTT opened a new plant in Mullheim, Germany to meet growing demand for high-end polymer pharmaceutical packaging. Construction began in 2020 and was completed in 2021, tripling the company's production of polymer containers used in syringes, IV therapies, and specialty medications.


• In October 2023, Stoelzle Pharma has introduced its brand new PharmaCos packaging line. The new PharmaCos line focuses on the packaging of products in the field of nutritional supplements and cosmeceuticals, where sustainability plays an important role, with a high recycled content of 73% for brown glass and 38% for white glass, as well as the low weight of the bottles.

Pharmaceutical Glass Packaging Market Segmentation

Pharmaceutical Glass Packaging Market by Product Type Outlook (USD Million, 2019-2032)

• Vials


• Bottles & Jars


• Cartridges & Syringes


• Ampoules

Pharmaceutical Glass Packaging Market by Material Type Outlook (USD Million, 2019-2032)

• TYPE I


• TYPE II


• TYPE III

Pharmaceutical Glass Packaging Market by Application Outlook (USD Million, 2019-2032)

• Generic Drugs


• Branded Drugs


• Biological Drugs

Global Pharmaceutical Glass Packaging Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  • Mexico
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Spain
  
  
  • Italy
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Middle East and Africa
  
  
  
  • Saudi Arabia
  
  
  • UAE
  
  
  • South Africa
  
  
  • Rest of Middle East and Africa
  
  
  
  


• South America
  
  
  
  • Argentina
  
  
  • Brazil
  
  
  • Rest of South America